New clinical study for 

Intermediate-risk

Prostate Cancer

Men who are 50+ with biopsy-confirmed prostate cancer might qualify for a investigational treatment that uses a small amount of steam to target cancer cells. 

Take a short survey to pre-qualify now.

What is the risk?

Prostate cancer illustration

Prostate cancer is one of the most common cancers among men, after skin cancer, but it can often be treated successfully when it has not spread outside of the prostate gland.

However, established prostate cancer treatments, such as undergoing a prostatectomy or radiation, may lead to complications such as incontinence or erectile dysfunction. 


This study is investigating the safety and effectiveness of a minimally invasive treatment that uses water vapor ablation to target the cancer cells.

Take a short survey to see if you pre-qualify.

You might be a candidate

This study, which is enrolling now, is intended for men:

doctor icon
doctor icon
doctor icon
Gleason score icon

50+, diagnosed with prostate cancer, with a life expectancy of at least 10 years.

Who have had an MRI within the last 12 months and biopsy confirmation within the past 6 months.

Who have not had previous prostate surgery and are willing to have study follow up for 5 years. 

Who have a Gleason Grade of 2 or Gleason Score of 7 (3+4)

Take the survey below to find out if you might be a candidate.

See if you pre-qualify.

Take a short quiz to evaluate if you may be a candidate for this investigational prostate cancer treatment.

 Health Treatment Solutions
© 2023 83bar